Lasa Supergenics Q3 FY26 Results: Board Approves Unaudited Financials, Auditor Notes Fire Impact
Lasa Supergenerics Limited's Board approved unaudited Q3 FY26 financial results on Feb 13, 2026. A fire on May 18, 2025, caused uninsured losses of ₹1273.62 lakhs (inventories) and ₹700 lakhs (PPE). Operations remain halted, impacting going concern status. Dormant bank balances and unconfirmed fixed deposits were noted.
The fire incident has led to a complete halt in production, significant uninsured losses, and raised doubts about the company's ability to continue as a going concern, which has a material impact on its operations and financial health.
The announcement details significant operational disruptions and financial impact due to an uninsured fire incident, raising concerns about the company's going concern status and highlighting dormant accounts.
Lasa Supergenerics Limited announced its unaudited financial results for the quarter ended December 31, 2025, following a Board of Directors meeting held on February 13, 2026. The meeting, which commenced at 2:00 PM and concluded at 3:15 PM, also reviewed the Limited Review Report from the Statutory Auditor for the same period.
The company's auditor, Gupta Rustagi & Co., highlighted significant issues in their review report. A fire incident on May 18, 2025, at the company's primary production unit in Lote Parshuram Industrial Area, Ratnagiri, Maharashtra, caused substantial damage to inventories, property, plant, and equipment, leading to a complete halt in operations. The affected assets were uninsured, resulting in a significant loss recognized as exceptional items, amounting to ₹1,273.62 lakhs for inventories, ₹700.00 lakhs for property, plant & equipment (provisional), and ₹83.85 lakhs for other expenses.
Furthermore, the auditor noted concerns regarding the company's going concern status, as management expressed an inability to resume manufacturing activities due to pending statutory clearances and operational constraints. The company is exploring contract manufacturing and/or leasing arrangements, subject to regulatory approvals. Bank account balances of ₹7.99 lakhs and fixed deposits of ₹31.46 lakhs as of December 31, 2025, were in dormant status and could not be confirmed. The auditor also mentioned that revenue recognition for a specific invoice is suspended due to force majeure, with advance received retained as a continuing liability pending legal outcomes.
Despite these issues, the auditor stated that nothing had come to their attention to suggest that the accompanying financial results, prepared in accordance with applicable accounting standards, contained material misstatements, apart from the possible effects of the aforementioned observations.
What to do with a filing like this
Lasa Supergenerics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lasa Supergenerics Limited. Read the original for the full detail.